International Journal of Medicine and Medical Sciences
Subscribe to IJMMS
Full Name*
Email Address*

Article Number - 545FCDC10


Vol.5(9), pp. 380-390 , September 2013
DOI: 10.5897/IJMMS2013.0902
ISSN: 2006-9723



Applications of recombinant protein therapeutic agents in periodontics contributors



Neha Sethi
  • Neha Sethi
  • Department of Periodontics College, IDEAS Dental College, Address, Gwalior, India.
  • Google Scholar







 Accepted: 29 March 2013  Published: 01 September 2013

Copyright © 2013 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0


Based on the improved understanding of cell and molecular biology of periodontal wound healing, the recombinant technology comprising rh growth factors and carrier construct is applied in periodontal regeneration. In 1997, the first recombinant (that is, synthetic) protein therapeutic agent was approved by the US Food and Drug Administration (FDA). In this paper we review the two commercially available recombinant agents, that is, rhPDGF-BB and rh-BMP-2 used for periodontal regeneration.

Key words: Periodontal regeneration, recombinant proteins, gene, tissue regeneration.

 

Allori AC, Sailon AM, Pan JH, Warren SM (2008). Biological basis of bone formation, remodeling, and repair-part III: biomechanical forces. Tissue Eng. Part B. Rev. 14(3):285-293.
http://dx.doi.org/10.1089/ten.teb.2008.0083
 
Barboza EP, Duarte MEL, Geolas L, Sorensen RG, Riedel GE, Wikesjo UME (2000). Effect of recombinant human bone morphogenetic protein 2 in an absorbable collagen sponge with space providing biomaterials on the augmentation of chronic alveolar ridge defects. J Periodontol 75:702-708.
http://dx.doi.org/10.1902/jop.2004.75.5.702
PMid:15212353
 
Barboza EP, Caúla AL, Caúla Fde O, de Souza RO, Geolás Neto L, Sorensen RG, Li XJ, Wikesjö UM (2004). Effect of recombinant human bone morphogenetic protein-2 in an absorbable collagen sponge with space-providing biomaterials on the augmentation of chronic alveolar ridge defects. J. Periodontol. 75(5):702-708.
http://dx.doi.org/10.1902/jop.2004.75.5.702
PMid:15212353
 
Bartold PM, Raben A (1992). Growth factor modulation of fibroblasts in stimulated wound healing. J. Periodont Res. 31:205-216.
http://dx.doi.org/10.1111/j.1600-0765.1996.tb00485.x
 
Bessho K, Kusumoto K, Fujimura K, Konishi Y, Ogawa Y, Tani Y, Iizuka T (1999) Comparison of recombinant and purified human bone morphogenetic protein. Br. J. Oral Maxillofac Surg. 37(1):2–5.
http://dx.doi.org/10.1054/bjom.1998.0379
PMid:10203213
 
Blom S, Holmstrup P, Dabelsteen E (1994). A comparison of the effect of EGF, PDGF and FGF on rat periodontal ligament fibroblast like cells DNA synthesis and morphology. J. Periodontol. 65:373.
http://dx.doi.org/10.1902/jop.1994.65.5.373
PMid:8046552
 
Boden SD (2001). Clinical applications of the BMPs. J Bone Joint Surg Am 83 A (Suppl 1) S161
 
Bouletreau PJ, Warren SM, Spector JA, Steinbrech DS, Mehrara BJ, Longaker MT (2002). factors in fracture microenvironment induce primary osteoblast angiogenic cytokine production. Plast Reconstr Surg. 110:139-148.
http://dx.doi.org/10.1097/00006534-200207000-00025
PMid:12087245
 
Bowen-Pope DF, Malpass TW, Foster DM Ross R (1988). platelet derived growth factor in vivo: Levels, activity, and rate of clearance. blood 64:458-469.
 
Boyan LA, Bhargava G, Nishimura F, Orman R, Price R, Terranova VP (1994). Mitogenic and chemotactic responses of human periodontal ligament cells to the different isoforms of platelet derived growth factor. J. Dent. Res. 73:1593.
PMid:7929973
 
Boyne PJ, Lilly LC, Marx RE, Moy PK, Nevins M, Spagnoli DB, Triplett RG (2005). De novo bone induction by recombinant human bone morphogenetic protein-2 (rhBMP-2) in maxillary sinus floor augmentation. J. Oral Maxillofac Surg. 63(12):1693-16707.
http://dx.doi.org/10.1016/j.joms.2005.08.018
PMid:16297689
 
Boyne PJ, Marx RE (1997). A feasibility study evaluating rhBMP-2/absorbable collagen sponge for maxillary sinus floor augmentation. Int J Periodontics Restorative Dent. 17(1):11-25.
PMid:10332250
 
Canalis E, McCarthy TL, Centrella M (1989). Effects of PDGF on bone formation in vitro. J. Cell Physiol. 140:530-537.
http://dx.doi.org/10.1002/jcp.1041400319
PMid:2777891
 
Cho TJ, Gerstenfeld LC, Einhorn TA (2002). Differential temporal expression of members of the transforming growth factor beta superfamily durring murine fracture healing. J Bone Miner Res. 17:513-520.
http://dx.doi.org/10.1359/jbmr.2002.17.3.513
PMid:11874242
 
Franchimont N, Rydziel S, Canalis E (1997). Interleukin 6 is autoregulated by transcriptional mechanisms in cultures of rat osteoblastic cells. J Clin Invest. 100(7):1797-803.
http://dx.doi.org/10.1172/JCI119707
PMid:9312180 PMCid:PMC508365
 
Glenn Walker, Ariel Hanson;; Ruwan Sumansinghe; Michelle Wall; Elizabeth Loboa (2005) Seeding of human mesenchymal stem cells onto poly-l-lactic acid (PLLA) scaffolds in a flow perfusion microfluidic chamber. Proceedings of the 2005 Summer Bioengineering Conference. 2005:1596-1597.
PMid:15762562
 
Giannobile WV, Hernandez RA, Finkelman RD, Ryan S, Kiritsy CP, D'Andrea M, Lynch SE (1996). Comparative effects of platelet derived growth factor–BB and insulin like growth factor–1, individually and in combination, on periodontal regeneration in Macaca fascicularis. J. Periodont Res. 31:301-312.
http://dx.doi.org/10.1111/j.1600-0765.1996.tb00497.x
PMid:8858534
 
Hadjiargyrou M, Lombardo F, Zhao S, Ahrens W, Joo J, Ahn H, Jurman M, White DW, Rubin CT (2002). Transcriptional profiling of bone regeneration :insight into the molecular complexity of wound repair. J Biol. Chem. 277:30177-30182.
http://dx.doi.org/10.1074/jbc.M203171200
PMid:12055193
 
Hanisch O, Sorensen RG, Kinoshita A, Spiekermann H, Wozney JM, Wikesjö UM (2003). Effect of recombinant human bone morphogenetic protein-2 in dehiscence defects with non-submerged immediate implants: an experimental study in Cynomolgus monkeys. J. Periodontol. 74(5):648-657.
http://dx.doi.org/10.1902/jop.2003.74.5.648
PMid:12816297
 
Hirota S, Imakita M, Kohri K, Ito A, Morii E, Adachi S, Kim HM, Kitamura Y, Yutani C, Nomura S (1993). Expression of osteopontin messenger RNA by macrophages in atherosclerotic plaques. A possible association with calcification. Am. J. Pathol. 143:1003–1008.
PMid:8213995 PMCid:PMC1887054
 
Hollinger JO, Hart CE, Hirsch SN, Lynch S, Friedlaender GE (2008). Recombinant human platelet-derived growth factor: Biology and clinical applications. J. Bone Joint Surg. Am. 90 Suppl 1:48-54.
http://dx.doi.org/10.2106/JBJS.G.01231
PMid:18292357
 
Hughes FJ, Aubin JE (1992). Differential chemotactic responses of different populations of fetal rat calvarial cells to PDGF and TGF beta. Bone mineral 19:63.
http://dx.doi.org/10.1016/0169-6009(92)90844-4
 
Huang JS, Huang SS, Deuel TF (1983). human platelet derived growth factor; Radioimmunoassay and discovery of a specific plasma-binding protein. J. Cell Biol. 97:383-388.
http://dx.doi.org/10.1083/jcb.97.2.383
PMid:6885904
 
KIMURA M, Akira S, Emiko S, Yoshinori K, Toshinori N, Fumihiko Y, Tsuyoshi K, Yoshiyuki H, Tomomi T, Noboru O (2013). Periodontal regeneration following application of basic fibroblast growth factor-2 in combination with beta tricalcium phosphate in class III furcation defects in dogs Dental Materials J. 32(2):256-262.
http://dx.doi.org/10.4012/dmj.2012-171
PMid:23538761
 
kugimiya F, Kawaguchi H, Kamekura S, Chikuda H, Ohba S, Yano F, Ogata N, Katagiri T, Harada Y, Azuma Y, Nakamura K, Chung UI (2005). Involvement of endogenous bone morphogenic protein (BMP-2) and BMP 6 in bone formation. J. Biol. Chem. 280:35704-35712.
 
Jonk C, Luigi J, Itoh S, Heldin C-H, Dijke P, Kruijer W (1998). Identi®cation and functional characterization of a Small binding element (SBE) in the JunB promoter that acts as a transforming growth factor-, activin, and bone morphogenetic protein-inducible enhancer. J Biol Chem 273:21145 - 21152.
http://dx.doi.org/10.1074/jbc.273.33.21145
PMid:9694870
 
Jovanovic SA, Hunt DR, Bernard GW, Spiekermann H, Nishimura R, Wozney JM, Wikesjö UME (2003). Long-term functional loading of dental implants in rhBMP-2 induced bone. A histologic study in the canine ridge augmentation model. Clin. Oral Implants Res. 14:793-803.
http://dx.doi.org/10.1046/j.0905-7161.2003.clr140617.x
PMid:15015957
 
Lim WH, Thomson RC, Cook AD, Wozney JM (2003). periodontal repair in dogs: Evaluation of a bioabsorbable space -providing macroporous membrane with recombinant human bone morphogenetic protein -2. J. Periodontol. 74:635-647.
http://dx.doi.org/10.1902/jop.2003.74.5.635
PMid:12816296
 
Lecanda F, Avioli LV, Cheng SL (1997). Regulation of bone matrix protein expression and induction of differentiation of human osteoblasts and human bone marrow stromal cells by bone morphogenetic protein-2. J. Cell Biochem. 67(3):386-396.
http://dx.doi.org/10.1002/(SICI)1097-4644(19971201)67:3<386::AID-JCB10>3.0.CO;2-B
 
Li G, Cui Y, McIlmurray L, Allen WE, Wang H (2005). rhBMP-2, rhVEGF(165), rhPTN and thrombin-related peptide, TP508 induce chemotaxis of human osteoblasts and microvascular endothelial cells. J Orthop Res. 23(3):680-685. Epub 2005 Apr 7.
http://dx.doi.org/10.1016/j.orthres.2004.12.005
PMid:15885491
 
Lynch SE, de Castilia, GR Williams, RC Kiritsy, CP Howell, TH Reddy, MS (1991). The effects of short term application of a comination of platelet derived and insulin like growth factor on periodontal wound healing. J. Periodontol. 62:458-467.
http://dx.doi.org/10.1902/jop.1991.62.7.458
PMid:1920013
 
Lynch SE (2008). Tissue engineering: Applications in maxillofacial surgery and periodondics. Chicago Quintessence.
 
Murakami S, Noda M (2000). expression of indian heghehog during fracture healing. calcif Tissue Int 2006. 66:272- 276.
 
McGuire MK, Kao RT, Nevins M, Lynch SE. rhPDGF-BB promotes healing of periodontal defects: 24-month clinical and radiographic observations. Int. J. Periodontics Restorative Dent. 2006, 26:223–
PMid:16836164
 
390 Int. J. Med. Med. Sci. 231.
 
Nakamura, CM, Takako H, Shigeyuki W, Toshiomi Y (2003). In vitro Proliferation of Human Bone Marrow Mesenchymal Stem Cells Employing Donor Serum and Basic Fibroblast Growth Factor, Cytotechnology. 43(1-3):89–96. doi: 10.1023/B:CYTO.0000039911.46200.61
http://dx.doi.org/10.1023/B:CYTO.0000039911.46200.61
 
Nevins M, Giannobile WV (2003). Platelet-derived growth factor stimulates bone fill and rate of attachment level gain: results of a large multicenter randomized controlled trial. J Periodontol. 76(12):2205-2215.
http://dx.doi.org/10.1902/jop.2005.76.12.2205
PMid:16332231
 
Nevins M, Giannobile WV, McGuire MK, Kao RT, Mellonig JT, Hinrichs JE, McAllister BS, Murphy KS, McClain PK, Nevins ML, Paquette DW, Han TJ, Reddy MS, Lavin PT, Genco RJ, Lynch SE (2005). Platelet-derived growth factor stimulates bone fill and rate of attachment level gain: Results of a large multicenter randomized controlled trial. J. Periodontol. 76:2205–2215.
http://dx.doi.org/10.1902/jop.2005.76.12.2205
PMid:16332231
 
Nevins M, Hanratty J, Lynch SE (2007). Clinical results using recombinant human platelet derived growth factor and mineralized freeze-dried bone allograft in periodontal defects. Int. J. Periodontics Restorative Dent. 27:421–427.
PMid:17990438
 
Oates TW, Rouse CA, Cochran DL (1993). Mitogenic effects of growth factors on human periodontal ligament cells in vitro. J. Periodontol. 64:142-148.
http://dx.doi.org/10.1902/jop.1993.64.2.142
PMid:8433255
 
Pietrzak WS, Eppley B (2005). Platelet rich plasma: Biology and new technology. J. Craniofac. Surg. 16:1043-1054.
http://dx.doi.org/10.1097/01.scs.0000186454.07097.bf
PMid:16327552
 
Piches JE, Carnes Dl, Graves DT (1992). Initial characterization of cells derived from human periodontium. J Periodont Res. 68:761-767.
 
Rajshankar O, McCulloch CAO, Tenenbaum HC, Lekic PC (1998). Osteogenic inhibition by rat periodontal ligament cells: modulation of bone morphogenic protein-7 adivity in vivo. Cell Tiss. Res. 294:475483.
http://dx.doi.org/10.1007/s004410051199
 
Rutherford RB, Ryan ME, Kennedy JE, Tucker MM, Charette MF (1993). Platelet–derived growth factor and dexamethasone combined with a collagen matrix induces regeneration of the periodontium in monkeys. J. Clin. Periodontal. 20:537-544.
http://dx.doi.org/10.1111/j.1600-051X.1993.tb00403.x
PMid:8354730
 
Risau W (1997). Mechanisms of angiogenesis. Nature 17;386(6626):671-6714.
 
Ripamonti U, Heliotis M, Van Den Heever B, Reddi AH (1994). Bone morphogenetic proteins induce periodontal regeneration in the baboon (Papio ursinus). J. Periodont Res. 29:439-445.
http://dx.doi.org/10.1111/j.1600-0765.1994.tb01216.x
PMid:7877080
 
Rosen V, Thies RS (1992). The BMP proteins in bone formation and repair. Trends Genet. 8:97-102.
http://dx.doi.org/10.1016/0168-9525(92)90063-A
 
 
Rydziel S, Durant D, Canalis E (2000). Platelet-derived growth factor induces collagenase 3 transcription in osteoblasts through the activator protein 1 complex. J. Cell Physiol. 184(3):326-333.
http://dx.doi.org/10.1002/1097-4652(200009)184:3<326::AID-JCP6>3.0.CO;2-S
 
Sutherland D, Bostrom M (2007). Grafts and bone graft substitutes. Lieberman JR page xvi.
 
Sigurdsson TJ, Lee MB, Kubota K (1993). Periodontal regenerative potential of space–providing expanded polytetrafluoroethylene membranes and recombinant human bone morphogenetic proteins. J. Periodontol. 65:511-521.
 
Schwartz MA, Ren XD (2000). Determination of GTP loading on Rho. Methods Enzymol. 325:264–272.
http://dx.doi.org/10.1016/S0076-6879(00)25448-7
 
van den Bergh JP, ten Bruggenkate CM, Groeneveld HH, Burger EH, Tuinzing DB (2000) Recombinant human bone morphogenetic protein-7 in maxillary sinus floor elevation surgery in 3 patients compared to autogenous bone grafts. A clinical pilot study. J. Clin. Periodontol. 27(9):627-636.
http://dx.doi.org/10.1034/j.1600-051x.2000.027009627.x
PMid:10983596
 
Wang HL, Pappert TD, Castelli WA, Chiego DJ Jr, Shyr Y, Smith BA (1994). The effect of platelet derived growth factor on the cellular response of the periodontium: An autoradiographic study. J. Periodontol.65:429.
http://dx.doi.org/10.1902/jop.1994.65.5.429
PMid:8046558
 
Wozney J, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, Hewick RM, Wang EA (1988). Novel regulators of bone formation: Molecular clones and activities. Science 242:1528-1534.
http://dx.doi.org/10.1126/science.3201241
PMid:3201241
 
Wikesjö UM, Xiropaidis AV, Thomson RC, Cook AD, Selvig KA, Hardwick WR (2003). Periodontal repair in dogs: space-providing ePTFE devices increase rhBMP-2/ACS-induced bone formation. J. Clin. Periodontol. 30(8):715-25.
http://dx.doi.org/10.1902/jop.2003.74.5.635
PMid:12931757
 
Wieman TJ, Smiell JM, Su Y (1998). Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study. Diabetes Care. May;21(5):822-827.
 
Yasko A W, Lane J M, Fellinger E J, Rosen V, Wozney J M, Wang EA (1992). The healing ofsegmental bone defects, induced by recombinant human bone morphogenetic protein (rhBMP-2), a radiographic, histological, and biomechanical study in rats. J. Bone Joint Surg. Am. 74:659-670
PMid:1378056
 
Zaman KU, Sugaya T, Kato H (1990). Effect of recombinant human platelet derived growth factor BB and bone morphogenetic protein 2 application to demineralized dentin on early periodontal ligament cell response. J. Periodontal Res. 34:244-250
http://dx.doi.org/10.1111/j.1600-0765.1999.tb02250.x
 
Zhao M, Qiao M, Oyajobi BO, Mundy GR, Chen D (2003) E3 ubiquitin ligase Smurf1 mediates core-binding factor alpha1/Runx2 degradation and plays a specific role in osteoblast differentiation. J Biol Chem. 278(30):27939-27944.
http://dx.doi.org/10.1074/jbc.M304132200
PMid:12738770
 

 

 


APA (2013). Applications of recombinant protein therapeutic agents in periodontics contributors. International Journal of Medicine and Medical Sciences, 5(9), 380-390.
Chicago Neha Sethi. "Applications of recombinant protein therapeutic agents in periodontics contributors." International Journal of Medicine and Medical Sciences 5, no. 9 (2013): 380-390.
MLA Neha Sethi. "Applications of recombinant protein therapeutic agents in periodontics contributors." International Journal of Medicine and Medical Sciences 5.9 (2013): 380-390.
   
DOI 10.5897/IJMMS2013.0902
URL http://academicjournals.org/journal/IJMMS/article-abstract/545FCDC10

Subscription Form